Role of magnesium in the pathogenesis and treatment of migraine

References

• Durlach J, Poenaru S, Rouhani S et al. The control of central neuronal hyperexcitability in magnesium deficiency. In: Essman WB (Ed.). Nutrients and Brain Function. Karger, Basel, Switzerland 48–71 (1987).
   Google Scholar
• Wagner CA. Disorders of renal magnesium handling explain renal magnesium transport. J. Nephrol.20, 507–510 (2007).
   PubMed Web of Science ®Google Scholar
• Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature366, 575–580 (1993).
   PubMed Web of Science ®Google Scholar
• Bapty BW, Dai LJ, Ritchie G et al. Activation of Mg2+/Ca2+ sensing inhibits hormone-stimulated Mg2+ uptake in mouse distal convoluted tubule cells. Am. J. Physiol.275, F353–F360 (1998).
   Google Scholar
• Hebert SC. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int.50, 2129–2139 (1996).
   PubMed Web of Science ®Google Scholar
• Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim. Care35(2), 215–237, v–vi (2008).
   PubMed Web of Science ®Google Scholar
• Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes. Res.14, 283–290 (2001).
   PubMed Web of Science ®Google Scholar
• Henrotte JG. Genetic regulation of red blood cell magnesium content and major histocompatibility complex. Magnesium1, 69–80 (1982).
   Google Scholar
• Laires MJ, Monteiro CP, Bicho M. Role of cellular magnesium in health and human disease. Front. Biosci.1, 262–276 (2004).
   Google Scholar
• Goksel BK, Torun D, Karaca S et al. Is low blood magnesium level associated with hemodialysis headache? Headache46, 40–45 (2006).
   PubMed Web of Science ®Google Scholar
• Whang R, Oei TO, Watanabe A. Frequency of hypomagnesemia in hospitalized patients receiving digitalis. Arch. Intern. Med.145, 655–656 (1985).
   PubMedGoogle Scholar
• Martin BJ. The magnesium load test: experience in elderly subjects. Aging (Milano)2, 291–296 (1990).
   PubMedGoogle Scholar
• Rob PM, Dick K, Bley N et al. Can one really measure magnesium deficiency using the short-term magnesium loading test? J. Intern. Med.246, 373–378 (1999).
   PubMed Web of Science ®Google Scholar
• Rubenowitz E, Axelsson G, Rylander R. Magnesium in drinking water and body magnesium status measured using an oral loading test. Scan. J. Clin. Lab. Invest.58, 423–428 (1998).
   PubMed Web of Science ®Google Scholar
• Innerarity S. Hypomagnesemia in acute and chronic illness. Crit. Care Nurs. Q.23, 1–19 (2000).
   PubMedGoogle Scholar
• Cholst IN, Steinberg SF, Tropper PJ et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N. Engl. J. Med.310, 1221–1225 (1984).
   PubMed Web of Science ®Google Scholar
• Eisenbud E, LoBue CC. Hypocalcemia after therapeutic use of magnesium sulfate. Arch. Intern. Med.136, 688–691 (1976).
   PubMedGoogle Scholar
• Broner CW, Stidham GL, Westenkirchner DF, Tolley EA. Hypermagnesemia and hypocalcemia as predictors of high mortality in critically ill pediatric patients. Crit. Care Med.18, 921–928 (1990).
   PubMed Web of Science ®Google Scholar
• Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am. J. Kidney Dis.37, 689–698 (2001).
   PubMed Web of Science ®Google Scholar
• Moskowitz MA. The neurobiology of vascular head pain. Ann. Neurol.16, 157–168 (1984).
   PubMed Web of Science ®Google Scholar
• Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med. Clin. N. Am.85, 911–941 (2001).
   PubMed Web of Science ®Google Scholar
• Leao AAP. Spreading depression of activity in cerebral cortex. J. Neurophysiol.7, 359–390 (1944).
   Google Scholar
• Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain117(Pt 1), 199–210 (1994).
   PubMed Web of Science ®Google Scholar
• Bures J, Buresova O, Drivanek J. The Mechanism and Applications of Leao’s Spreading Depression of Electroencephalographic Activity. Academic Press, NY, USA (1974).
   Google Scholar
• Kruger H, Heinemann U, Luhmann HJ. Effects of ionotropic glutamate receptor blockagde and 5-HT1A receptor activation on spreading depression in rat neocortical slices. Neuroreport10, 2651–2656 (1999).
   PubMed Web of Science ®Google Scholar
• Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol. Rev.81, 1065–1096 (2001).
   PubMed Web of Science ®Google Scholar
• Gorelova NA, Koroleva VI, Amemori T et al. Ketamine blockade of cortical spreading depression in rats. Electroencephalogr. Clin. Neurophysiol.66, 440–447 (1987).
   PubMedGoogle Scholar
• Gorji A, Scheller D, Straub H et al. Spreading depression in human neocortical slices. Brain Res.906, 74–83 (2001).
   PubMed Web of Science ®Google Scholar
• Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl Acad. Sci. USA98, 4687–4692 (2001).
   PubMed Web of Science ®Google Scholar
• Strong AJ, Fabricius M, Boutelle MG et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke33, 2738–2743 (2002).
   PubMed Web of Science ®Google Scholar
• Strong AJ. Detecting and characterizing spreading depression in the injured human brain. J. Cereb. Blood Flow Metab.23, 748 (2003).
   PubMed Web of Science ®Google Scholar
• Fabricius M, Fuhr S, Bhatia R et al. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain129, 778–790 (2006).
   PubMed Web of Science ®Google Scholar
• Mayevsky A, Doiron A, Manor T et al. Cortical spreading depression recorded from the human brain using a multiparametric monitoring system. Brain Res.740, 268–274 (1006).
   Google Scholar
• Wahl M, Schilling L, Parsons AA et al. Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res.637, 204–210 (1994).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol.28, 183–187 (1990).
   PubMed Web of Science ®Google Scholar
• Durlach J. Neurological manifestations of magnesium imbalance. In: Handbook of Clinical Neurology. Vinken PJ, Bruyn GW (Eds). North-Holland Publishing Co., Amsterdam, Holland 28, 545–579 (1976).
   Google Scholar
• Jain AC, Sethi NC, Balbar PK. A clinical electroencephalographic and trace element study with special reference to zinc, copper and magnesium in serum and cerebrospinal fluid (CSF) in cases of migraine. J. Neurol. Suppl.232, 161 (1985).
   Google Scholar
• Ramadan NM, Halvorson H, Vande-Linde A et al. Low brain magnesium in migraine. Headache29, 590–593 (1989).
   PubMed Web of Science ®Google Scholar
• Boska MD, Welch KMA, Barker PB et al. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology58, 1227–1233 (2002).
   PubMed Web of Science ®Google Scholar
• Aurora SK, Ahmad BK, Welch KM et al. Transcranial magnetic stimulations confirms hyperexcitability of occipital cortex in migraine. Neurology50, 1111–1114 (1998).
   PubMed Web of Science ®Google Scholar
• Lodi R, Iotti S, Cortelli P, Pierangeli G et al. Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Res. Bull.54, 437–441 (2001).
   PubMed Web of Science ®Google Scholar
• Gallai V, Sarchielli P, Costa G et al. Serium and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache32, 132–135 (1992).
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V. Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia12, 21–27 (1992).
   PubMed Web of Science ®Google Scholar
• Trauninger A, Pfund Z, Koszegi T, Czopf J. Oral magnesium load test in patients with migraine. Headache42, 114–119 (2002).
   PubMed Web of Science ®Google Scholar
• Mauskop A, Altura BT, Cracco RQ, Altura BM. Deficiency in serum inionized magnesium but not total magnesium in patients with migraines. Possible role of ICa2+/IMg2+ ratio. Headache33, 135–138 (1993).
   PubMed Web of Science ®Google Scholar
• Thomas J, Thomas E, Tomb E. Serum and erythrocyte magnesium concentrations and migraine. Magnes. Res.5, 127–130 (1992).
   PubMedGoogle Scholar
• Schoenen J, Sianard-Gainko J, Lenaerts M. Blood magnesium levels in migraine. Cephalalgia11, 97–99 (1991).
   PubMedGoogle Scholar
• Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache31, 298–301 (1991).
   PubMed Web of Science ®Google Scholar
• Smeets MC, Vernooy CB, Souverjin JHM, Ferrari MD. Intracellular and plasma magnesium in familial hemiplegic migraine and migraine with and without aura. Cephalalgia14, 29–32 (1994).
   PubMed Web of Science ®Google Scholar
• Gallai V, Sarchielli P, Morucci P, Abbritti G. Red blood cell magnesium levels in migraine patients. Cephalalgia13, 94–98 (1993).
   PubMedGoogle Scholar
• Gallai V, Sarchielli P, Morucci P, Abbritti G. Magnesium content of monomuclear blood cells in migraine patients. Headache34, 160–165 (1994).
   PubMed Web of Science ®Google Scholar
• Soriani S, Arnaldi C, De Carlo L et al. Serum and red blood cell magnesium levels in juvenile migraine patients. Headache35, 14–16 (1995).
   PubMed Web of Science ®Google Scholar
• Thomas J, Millot JM, Sebille S, Delabroise AM et al. Free and total magnesium in lymphocytes of migraine patients – effect of magnesium-rich mineral water intake. Clin. Chim. Acta.295, 64–75 (2000).
   Google Scholar
• Touitou Y, Godaud JP, Ferment O et al. Prevalence of magnesium and potassium deficiencies in the elderly. Clin. Chem.33, 518–523 (1987).
   PubMed Web of Science ®Google Scholar
• Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J. Neurophysiol.57, 869–888 (1987).
   PubMed Web of Science ®Google Scholar
• Coan EJ, Collingridge GL. Magnesium ions block an N-methyl D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci. Lett.53, 21–26 (1985).
   PubMed Web of Science ®Google Scholar
• Baudouin-Legros M, Dard B, Guichency P. Hyperreactivity of platelets from spontaneously hypertensive rats. Role of external magnesium. Hypertension8, 694–699 (1986).
   PubMed Web of Science ®Google Scholar
• Altura BT, Altura BM. Withdrawal of magnesium causes vasospasm while elevated magnesium produced relaxation of tone in cerebral arteries. Neurosci. Lett.20, 323–327 (1989).
   Google Scholar
• Altura BT, Altura BM. The role of magnesium in etiology of strokes and cerebrovasospasm. Magnesium1, 277–291 (1982).
   Google Scholar
• Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am. J. Physiol.263(Pt 2), R734–R737 (1992).
   PubMed Web of Science ®Google Scholar
• Foster AC, Fagg GE. Neurobiology. Taking apart NMDA receptors. Nature329, 395–396 (1987).
   PubMed Web of Science ®Google Scholar
• Huang QF, Gebrewold A, Zhang A et al. Role of excitatory amino acids in regulation of rat pial microvasculature. Am. J. Physiol.266, R158–R163 (1994).
   Google Scholar
• Ferrari MD. Biochemistry of migraine. Pathol. Biol.40, 287–292 (1992).
   PubMedGoogle Scholar
• Ochs S. The nature of spreading depression in neural networks. Int. Rev. Neruobiol.4, 1–69 (1962).
   Web of Science ®Google Scholar
• Van Harreveld A, Fifkova E. Mechanisms involved in spreading depression. J. Neurobiol.4, 375–387 (1973).
   PubMedGoogle Scholar
• Van Harreveld A. The nature of the chick’s magnesium-sensitive retinal spreading depression. J. Neurobiol.15, 333–343 (1984).
   PubMedGoogle Scholar
• van der Hel WS, van den Bergh WM, Nicolay K, Tulleken KA, Dijkhuizen RM. Suppression of cortical spreading depressions after magnesium treatment in the rat. Neuroreport9, 2179–2182 (1998).
   PubMed Web of Science ®Google Scholar
• Nechifor M, Chelarescu D, Mifitode M. Magnesium influence on morphine-induced pharmacodependence in rats. Magnes. Res.17, 7–13 (2004).
   PubMed Web of Science ®Google Scholar
• Nechifor M. Magnesium in drug dependences. Magnes. Res.21, 5–15 (2008).
   PubMed Web of Science ®Google Scholar
• Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology49, 201–206 (1997).
   PubMed Web of Science ®Google Scholar
• Rozen TD. Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulfate. Headache43, 901–903 (2003).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol.28, 183–187 (1990).
   PubMed Web of Science ®Google Scholar
• Dubner R. Recent advances in our understanding of pain. In: Oro-facial Pain and Neuromuscular Dysfunction: Mechanisms and Clinical Correlates. Klineberg I, Sessle B (Eds). Pergamon Press, Oxford, UK 3-19.9 (1985).
   Google Scholar
• Coderre TI, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain52, 259–285 (1993).
   PubMed Web of Science ®Google Scholar
• Myrdal U, Leppert J, Edvinsson L et al. Magnesium sulphate infusion decreases circulating calcitonin gene-related peptide (CGRP) in women with primary Raynaud’s phenomenon. Clin. Physiol.14, 539–546 (1994).
   PubMedGoogle Scholar
• Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain52, 127–136 (1993).
   PubMed Web of Science ®Google Scholar
• Choi YB, Lipton SA. Redox modulation of the NMDA receptor. Cell Mol. Life Sci.57, 1535–1541 (2000).
   PubMed Web of Science ®Google Scholar
• Olesen J, Thomsen LL, Eversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci.15, 149–153 (1994).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Iversen HK, Brinck TA et al. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine suffers. Cephalalgia13, 395–399 (1993).
   PubMed Web of Science ®Google Scholar
• Lassen LH, Ashina M, Christiansen I et al. Nitric oxide synthase inhibition: a new principal in the treatment of migraine attacks. Cephalalgia18, 27–32 (1998).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Migraine: emerging treatment options for preventive and acute attack therapy. Expert Opin. Emerg. Drugs11, 419–427 (2006).
   PubMedGoogle Scholar
• Reuter U, Bolay H, Jansen-Olesen I et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain124, 2490–2502 (2001).
   PubMed Web of Science ®Google Scholar
• Hoskin KL, Bulmer DCE, Goadsby PJ. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci. Lett.266, 173–176 (1999).
   PubMed Web of Science ®Google Scholar
• Altura BT, Altura BM. Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br. J. Pharmacol.91, 449–451 (1987).
   PubMed Web of Science ®Google Scholar
• Altura BM, Turlapaty PDMV. Withdrawal of magnesium enhances coronary arterial spasm produced by vasoactive agents. Br. J. Pharmacol.77, 649–659 (1982).
   PubMed Web of Science ®Google Scholar
• Peters JA, Hales TG, Lambert JJ. Divalent cations modulate 5-HT3 receptor-induced currents in N1E-115 neuroblastoma cells. Eur. J. Pharmacol.151, 491–495 (1988).
   PubMed Web of Science ®Google Scholar
• Goldstein S, Zsoter TT. The effect of magnesium on the response of smooth muscle to 5-hydroxytryptamine. Br. J. Pharmacol.62, 507–514 (1978).
   PubMed Web of Science ®Google Scholar
• Altura BT, Shirley T, Young CC, Dell’Ofrano K, Handwerker SM, Altura BM. A new method for the rapid determination of ionized Mg2+ in whole blood, serum and plasma. Meth. Find. Exp. Clin. Pharmacol.14(4), 297–304 (1992).
   PubMedGoogle Scholar
• Altura BT, Shirley TL, Young CC et al. Characterization of a new ion selective electrode for ionized magnesium in whole blood, plasma, serum and aqueous samples. Scan. J. Clin. Lab. Invest.54(Suppl. 217), 21–36 (1994).
   Web of Science ®Google Scholar
• Mauskop A, Altura BT, Cracco RQ et al. Intravenous magnesium sulfate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin. Sci.89, 633–636 (1995).
   PubMed Web of Science ®Google Scholar
• Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache36, 154–160 (1996).
   PubMed Web of Science ®Google Scholar
• Mauskop A, Altura BT, Cracco RQ, Altura BM. Chronic daily headache – one disease or two? Diagnostic role of serum ionized magnesium. Cephalalgia14, 24–28 (1994).
   PubMed Web of Science ®Google Scholar
• Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia16, 257–263 (1996).
   PubMed Web of Science ®Google Scholar
• Pfaffenrath V, Wessely P, Meyer C et al. Magnesium in the prophylaxis of migraine-A double-blind, placebo-controlled study. Cephalalgia16, 436–440 (1996).
   PubMed Web of Science ®Google Scholar
• Koseoglu E, Talashoglu A, Gonul AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Mag. Res.21, 101–108 (2008).
   PubMed Web of Science ®Google Scholar
• Aloisi P, Marelli A, Porto C, Tozzi E. Cerone G. Visual evoked potentials and serum magnesium levels in migraine patients. Headache37, 383–385 (1997).
   PubMed Web of Science ®Google Scholar
• Mirza M, Tutus A, Erdogan F et al. Interictal SPECT with Tc-99m HMPAO studies in migraine patients. Acta Neurol. Belg.98, 190–194 (1998).
   PubMed Web of Science ®Google Scholar
• Maini CL, Turco GL, Castellano G et al. Cerebral blood flow and volume in symptom-free migraineurs: a SPECT study. Nuklearmedizin29, 210–214 (1990).
   PubMedGoogle Scholar
• Ramadan NM, Levine SR, Welch KMA. Interictal cerebral blood flow asymmetries in migraine with aura. Cephalalgia11(Suppl.), 42–43 (1991).
   Web of Science ®Google Scholar
• Ferrari MD, Haan J, Blokland JA et al. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch. Neurol.52, 135–139 (1995).
   PubMedGoogle Scholar
• Olesen J, Laurtizen M, Tfelt-Hansen P, Henriksen L, Larsen B. Spreading cerebral oligemia in classical and normal cerebral blood flow in common migraine. Headache22, 242–248 (1982).
   PubMed Web of Science ®Google Scholar
• Mauskop M, Altura BM. Magnesium for migraine: rationale for use and theapeutic potential. CNS Drugs9, 185–190 (1998).
   Web of Science ®Google Scholar
• Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache41, 171–177 (2001).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia22, 345–353 (2002).
   PubMed Web of Science ®Google Scholar
• Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann. Emerg. Med.38, 621–627 (2001).
   PubMed Web of Science ®Google Scholar
• Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the emergency department. Cephalalgia25, 199–204 (2005).
   PubMed Web of Science ®Google Scholar
• Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate relieves cluster hedaches in patients with low serum ionized magnesium levels. Headache35, 597–600 (1995).
   PubMed Web of Science ®Google Scholar
• Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache42, 242–248 (2002).
   PubMed Web of Science ®Google Scholar
• Abraham GE, Lubran MM. Serum and red cell magnesium levels in patients with premenstrual tension. Am. J. Clin. Nutr.34, 2364–2366 (1981).
   PubMed Web of Science ®Google Scholar
• Mazzotta G, Srachielli P, Alberti A, Gallai V. Intracellular Mg2+ concentration and electomyographical ischemic test in juvenile headache. Cephalalgia19, 802–809 (1999).
   PubMed Web of Science ®Google Scholar
• Galland L. Magnesium, stress, and neuropsyhiatric diorders. Magn. Trace Elements10, 287–301 (1991).
   PubMedGoogle Scholar
• Wang F, Van Den Eeden SK, Ackerson LM et al. Oral magnesium oxide prophylaxis of frequent migraine headache in children: a randomized, double-blind, placebo-controlled trial. Headache43, 601–610 (2003).
   PubMed Web of Science ®Google Scholar
• Lampl Y, Geva D, Gilad R et al. Cerebrospinal fluid magnesium level as a prognostic factor in ischaemic stroke. J. Neurol.245, 584–588 (1998).
   PubMed Web of Science ®Google Scholar
• McIntosh TK, Faden AI, Yamakami I, Vink R. Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioural studies. J. Neurotrauma5, 17–30 (1988).
   PubMed Web of Science ®Google Scholar
• Vink R, McIntosh TK, Demediuk P et al. Decline in intracellular free Mg2+ is associated with irreversible tissue injury after brain trauma. J. Biol. Chem.263, 757–761 (1988).
   PubMed Web of Science ®Google Scholar
• Helpern JA, Vande Linde AMQ, Welch KMA et al. Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia. Neurology43, 1577–1581 (1993).
   PubMed Web of Science ®Google Scholar
• Vink R, Heath DL, McIntosh TK. Acute and prolonged alterations in brain free magnesium following fluid percussion-induced brain trauma in rats. J. Neurochem.66, 2477–2483 (1996).
   PubMed Web of Science ®Google Scholar
• Lee M-S, Wu YS, Yang DY et al. Significantly decreased extracellular magnesium in brains of gerbils subjected to cerebral ischaemia. Clin. Chim. Acta.318, 121–125 (2002).
   PubMed Web of Science ®Google Scholar
• Vande Linde AMQ, Chopp M. Chronic changes in brain Mg2+ concentrations after forebrain ischemia in the rat. Metab. Brain Dis.6, 199–206 (1991).
   PubMed Web of Science ®Google Scholar
• Meloni BP, Knuckey NW. Is magnesium neuroprotective following global and focal cerebral ischaemia? A review of published studies. Magnes. Res.19, 123–137 (2006).
   PubMed Web of Science ®Google Scholar
• Tsuda T, Kogure K, Nishioka K, Watanabe T. Mg2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus. Neuroscience44, 335–341 (1991).
   PubMed Web of Science ®Google Scholar
• Okawa M. Effects of magnesium sulfate on brain damage by complete global brain ischemia (Japanese). Masui41, 341–355 (1992).
   PubMedGoogle Scholar
• Sirin BH, Coskun E, Yilik L et al. Neuroprotective effects of preischemia subcutaneous magnesium sulfate in transient cerebral ischemia. Eur. J. Cardiothorac. Surg.14, 82–88 (1998).
   PubMed Web of Science ®Google Scholar
• Miles AN, Majda BT, Melomi BP, Knuckey NW. Post-ischemia intravenous administration of magnesium sulfate inhibits hippocampal CA1 neuronal death after transient global ischemia in rats. Neurosurgery49, 1443–1451 (2001).
   PubMed Web of Science ®Google Scholar
• Zhou H, Ma U, Zhou Y et al. Effects of magnesium sulphate on neuron apoptosis and expression of caspase-3 bax and bcl-2 after cerebral ischemia-reperfusion injury. Chin. Med. J. (Engl.)116, 1532–1534 (2003).
   PubMed Web of Science ®Google Scholar
• Blair JL, Warner DS, Todd MM. Effects of elevated plasma magnesium versus calcium on cerebral ischemic injury in rats. Stroke20, 507–512 (1989).
   PubMed Web of Science ®Google Scholar
• Milani H, Lepri ER, Giordani F, Favero-Filho LA. Magnesium chloride alone or in combination with diazepam fails to prevent hippocampal damage following transient forebrain ischemia. Braz. J. Med. Biol. Res.32, 1285–1293 (1999).
   PubMed Web of Science ®Google Scholar
• Zhu H-D, Meloni BP, Moore SR et al. Intravenous administration of magnesium is only neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia. Brain Res.1014, 53–60 (2004).
   PubMed Web of Science ®Google Scholar
• Zhu H-D, Meloni BP, Bojarski C et al. Post-ischemic modest hypothermia (35C) combined with intravenous magnesium is more effective at reducing CA1 death than either treatment used alone following global cerebral ischemia in rats. Exp. Neurol.193, 361–368 (2005).
   PubMed Web of Science ®Google Scholar
• Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomized controlled trial. Lancet363, 439–445 (2004).
   PubMed Web of Science ®Google Scholar
• Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy –Magnesium (FAST-MAG) pilot trial. Stroke35, E106–E108 (2004).
   PubMed Web of Science ®Google Scholar
• Kuban KCK, Leviton A. Cerebral palsy. N. Engl. J. Med.330, 188–195 (1994).
   PubMed Web of Science ®Google Scholar
• Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics95, 263–269 (1995).
   PubMed Web of Science ®Google Scholar
• Rouse DJ, Hirtz, DG, Thom E et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N. Engl. J. Med.359, 895–905 (2008).
   PubMed Web of Science ®Google Scholar